These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway. Shah K; Panchal S; Patel B Pharmacol Res; 2021 May; 167():105532. PubMed ID: 33677106 [TBL] [Abstract][Full Text] [Related]
3. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203 [TBL] [Abstract][Full Text] [Related]
4. The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Reverses Immune Evasion in Wnt Ligand-dependent Cancer Models. Phillips C; Bhamra I; Eagle C; Flanagan E; Armer R; Jones CD; Bingham M; Calcraft P; Edmenson Cook A; Thompson B; Woodcock SA Cancer Res Commun; 2022 Sep; 2(9):914-928. PubMed ID: 36922934 [TBL] [Abstract][Full Text] [Related]
5. Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand-Addicted Pancreatic Cancer. Aguilera KY; Le T; Riahi R; Lay AR; Hinz S; Saadat EA; Vashisht AA; Wohlschlegel J; Donahue TR; Radu CG; Dawson DW Mol Cancer Ther; 2022 Jun; 21(6):936-947. PubMed ID: 35313331 [TBL] [Abstract][Full Text] [Related]
6. Modulating Wnt signaling at the root: Porcupine and Wnt acylation. Torres VI; Godoy JA; Inestrosa NC Pharmacol Ther; 2019 Jun; 198():34-45. PubMed ID: 30790642 [TBL] [Abstract][Full Text] [Related]
7. The Functional Landscape of Patient-Derived RNF43 Mutations Predicts Sensitivity to Wnt Inhibition. Yu J; Yusoff PAM; Woutersen DTJ; Goh P; Harmston N; Smits R; Epstein DM; Virshup DM; Madan B Cancer Res; 2020 Dec; 80(24):5619-5632. PubMed ID: 33067269 [TBL] [Abstract][Full Text] [Related]
8. Novel PORCN inhibitor WHN-88 targets Wnt/β-catenin pathway and prevents the growth of Wnt-driven cancers. Yang Q; Qin T; An T; Wu H; Xu G; Xiang J; Lei K; Zhang S; Xia J; Su G; Wang D; Xue M; Kong L; Zhang W; Wu S; Li Y Eur J Pharmacol; 2023 Apr; 945():175628. PubMed ID: 36858339 [TBL] [Abstract][Full Text] [Related]
9. Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors. Dong Y; Li K; Xu Z; Ma H; Zheng J; Hu Z; He S; Wu Y; Sun Z; Luo L; Li J; Zhang H; Zhang X Bioorg Med Chem; 2015 Nov; 23(21):6855-68. PubMed ID: 26455655 [TBL] [Abstract][Full Text] [Related]
10. Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3-mutant neoplasia. Koo BK; van Es JH; van den Born M; Clevers H Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7548-50. PubMed ID: 26023187 [TBL] [Abstract][Full Text] [Related]
11. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Liu J; Pan S; Hsieh MH; Ng N; Sun F; Wang T; Kasibhatla S; Schuller AG; Li AG; Cheng D; Li J; Tompkins C; Pferdekamper A; Steffy A; Cheng J; Kowal C; Phung V; Guo G; Wang Y; Graham MP; Flynn S; Brenner JC; Li C; Villarroel MC; Schultz PG; Wu X; McNamara P; Sellers WR; Petruzzelli L; Boral AL; Seidel HM; McLaughlin ME; Che J; Carey TE; Vanasse G; Harris JL Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20224-9. PubMed ID: 24277854 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells. Kleszcz R; Szymańska A; Krajka-Kuźniak V; Baer-Dubowska W; Paluszczak J Cell Oncol (Dordr); 2019 Aug; 42(4):505-520. PubMed ID: 31089983 [TBL] [Abstract][Full Text] [Related]
13. Porcupine-dependent Wnt activity within the uterine epithelium is essential for fertility. Farah O; Biechele S; Rossant J; Dufort D Biol Reprod; 2017 Nov; 97(5):688-697. PubMed ID: 29036275 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the 'reversed' amide scaffold. Xu Z; Xu X; O'Laoi R; Ma H; Zheng J; Chen S; Luo L; Hu Z; He S; Li J; Zhang H; Zhang X Bioorg Med Chem; 2016 Nov; 24(22):5861-5872. PubMed ID: 27692509 [TBL] [Abstract][Full Text] [Related]
15. Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma. Li J; Wu G; Xu Y; Li J; Ruan N; Chen Y; Zhang Q; Xia Q Biomed Res Int; 2020; 2020():2527643. PubMed ID: 32104684 [TBL] [Abstract][Full Text] [Related]
16. WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma. Zimmerli D; Cecconi V; Valenta T; Hausmann G; Cantù C; Restivo G; Hafner J; Basler K; van den Broek M Oncogene; 2018 Jul; 37(27):3753-3762. PubMed ID: 29662191 [TBL] [Abstract][Full Text] [Related]
17. Opposing actions of renal tubular- and myeloid-derived porcupine in obstruction-induced kidney fibrosis. Lu X; Rudemiller NP; Ren J; Wen Y; Yang B; Griffiths R; Privratsky JR; Madan B; Virshup DM; Crowley SD Kidney Int; 2019 Dec; 96(6):1308-1319. PubMed ID: 31585741 [TBL] [Abstract][Full Text] [Related]
18. Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI. Agarwal P; Zhang B; Ho Y; Cook A; Li L; Mikhail FM; Wang Y; McLaughlin ME; Bhatia R Blood; 2017 Feb; 129(8):1008-1020. PubMed ID: 28011678 [TBL] [Abstract][Full Text] [Related]